Apyx Medical (APYX) EBT (2011 - 2026)

Apyx Medical (APYX) has reported EBT for 16 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 20.09% year-over-year to -$2.9 million; the trailing twelve-month figure through Jun 2026 stood at -$11.0 million (up 43.64% YoY), and the FY2025 full-year result was -$13.9 million, up 46.22% from the prior year.
• EBT retreated to -$2.9 million in Q2 2026 per APYX's latest filing, from -$2.0 million in the prior quarter.
• Across five years, EBT topped out at -$953000.0 in Q2 2023 and bottomed at -$9.5 million in Q4 2023.
• Historically, EBT has averaged -$4.9 million across 5 years, with a median of -$5.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: EBT jumped 82.2% in 2023, then tumbled 585.83% in 2024.
• Over 5 years, EBT stood at -$5.9 million in 2022, then plunged by 61.26% to -$9.5 million in 2023, then grew by 26.34% to -$7.0 million in 2024, then jumped by 40.7% to -$4.2 million in 2025, then advanced by 29.24% to -$2.9 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$2.9 million, -$2.0 million, and -$4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.